| CERVOMED INC. DL-,001 |
| USA |
| Gesundheit |
| US15713L1098 / A3ES01 |
| DP8 (Frankfurt) / CRVO (NASDAQ) |
| FRA:DP8, ETR:DP8, DP8:GR, NASDAQ:CRVO |
| - |
| https://www.cervomed.com/ |
|
CervoMed Inc. Common Stock represents CervoMed Inc., a clinical-stage biotechnology company focused on developing treatments for age-related neurologic disorders. The company’s current work centers on advancing CNS-focused therapeutics designed to ..
>Volltext.. |
| 43.46 Mio. EUR |
| 21.61 Mio. EUR |
| 0.3 Mio. EUR |
| -27.82 Mio. EUR |
| -27.1 Mio. EUR |
| -2.87 EUR |
| - |
| 20.05 Mio. EUR |
| -24.98 Mio. EUR |
| 8.22 |
| -95.61% |
| -38.44% |
| - |
| - |
| - |
| - |
| CERVOMED |
| 12.10.26 |
|